|
1
|
Ferlay J, Shin HR, Bray F, et al:
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int
J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen YT, Feng B and Chen LB: Update of
research on drug resistance in small cell lung cancer chemotherapy.
Asian Pac J Cancer Prev. 13:3577–3581. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Volm M, Koomägi R, Mattern J, et al:
Protein expression profiles indicative for drug resistance of
non-small cell lung cancer. Br J Cancer. 87:251–257. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun QL, Sha HF, Yang XH, et al:
Comparative proteomic analysis of paclitaxel sensitive A549 lung
adenocarcinoma cell line and its resistant counterpart A549-Taxol.
J Cancer Res Clin Oncol. 137:521–532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kfoury A, Virard F, Renno T and Coste I:
Dual function of MyD88 in inflammation and oncogenesis:
implications for therapeutic intervention. Curr Opin Oncol.
26:86–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang EL, Qian ZR, Nakasono M, et al: High
expression of Toll-like receptor 4/myeloid differentiation factor
88 signals correlates with poor prognosis in colorectal cancer. Br
J Cancer. 102:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kelly MG, Alvero AB, Chen R, et al: TLR-4
signaling promotes tumor growth and paclitaxel chemoresistance in
ovarian cancer. Cancer Res. 66:3859–3868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szajnik M, Szczepanski MJ, Czystowska M,
et al: TLR4 signaling induced by lipopolysaccharide or paclitaxel
regulates tumor survival and chemoresistance in ovarian cancer.
Oncogene. 28:4353–4363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Silasi DA, Alvero AB, Illuzzi J, et al:
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian
cancer. Yale J Biol Med. 79:153–163. 2006.PubMed/NCBI
|
|
10
|
Duan Z, Feller AJ, Penson RT, et al:
Discovery of differentially expressed genes associated with
paclitaxel resistance using cDNA array technology: analysis of
interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the
paclitaxel-resistant phenotype. Clin Cancer Res. 5:3445–3453.
1999.
|
|
11
|
Xiang WQ, Feng WF, Ke W, et al: Hepatitis
B virus X protein stimulates IL-6 expression in hepatocytes via a
MyD88-dependent pathway. J Hepatol. 54:26–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szczepanski MJ, Czystowska M, Szajnik M,
et al: Triggering of Toll-like receptor 4 expressed on human head
and neck squamous cell carcinoma promotes tumor development and
protects the tumor from immune attack. Cancer Res. 69:3105–3113.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang B, Chen R, Wang T, et al: Myeloid
differentiation factor 88 promotes growth and metastasis of human
hepatocellular carcinoma. Clin Cancer Res. 19:2905–2916. 2013.
View Article : Google Scholar
|
|
14
|
Crown J and O’Leary M: The taxanes: an
update. Lancet. 355:1176–1178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schiff PB and Horwitz SB: Taxol stabilizes
microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA.
77:1561–1565. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Horwitz SB, Lothstein L, Manfredi JJ, et
al: Taxol: mechanisms of action and resistance. Ann NY Acad Sci.
466:733–744. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamamoto K, Ichijo H and Korsmeyer SJ:
BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal
protein kinase pathway normally activated at G2/M. Mol
Cell Biol. 19:8469–8478. 1999.PubMed/NCBI
|
|
18
|
Gonçalves A, Braguer D, Carles G, et al:
Caspase-8 activation independent of CD95/CD95-L interaction during
paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).
Biochem Pharmacol. 60:1579–1584. 2000.PubMed/NCBI
|
|
19
|
Castoldi A, Braga TT, Correa-Costa M, et
al: TLR2, TLR4 and the MYD88 signaling pathway are crucial for
neutrophil migration in acute kidney injury induced by sepsis. PLoS
One. 7:e375842012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haley K, Igyártó BZ, Ortner D, et al:
Langerhans cells require MyD88-dependent signals for Candida
albicans response but not for contact hypersensitivity or
migration. J Immunol. 188:4334–4339. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Penson RT, Kronish K, Duan Z, et al:
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in
patients with epithelial ovarian cancer and their relationship to
treatment with paclitaxel. Int J Gynecol Cancer. 10:33–41. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arenberg DA, Kunkel SL, Polverini PJ, et
al: Inhibition of interleukin-8 reduces tumorigenesis of human
non-small cell lung cancer in SCID mice. J Clin Invest.
97:2792–2802. 1996. View Article : Google Scholar : PubMed/NCBI
|
